It is a pharma private limited company based in Valsad, Gujarat, India, established in 2018.
2018 | Valsad, Gujarat, India | ActiveAlbero Pharma Private Limited, a active private limited company, was established on 16 October 2018 in Valsad, Gujarat, India. Engaging in drug formulation & development within the manufacturing sector, it holds CIN: U33112GJ2018PTC104775. Registered under ROC Roc Ahmedabad. it is unlisted. It has an authorized capital of ₹1.00 M and a paid-up capital of ₹1.00 M.
It upholds a compliant status. Its leadership includes Chandraben Hiralal Thakkar (Director), Vishal Rajendrabhai Chaudhari (Director), Karunendra Pandey (Director). Past directors included Chandraben Hiralal Thakkar, Vishal Rajendrabhai Chaudhari, Ashishkumar Prabhunarayan Singh Thakur. Its latest AGM occurred on 30 September 2024, with the balance sheet filed on 31 March 2024. It is based at P-491/2 492 1 2 3, Shop No. 105, Amidhara Complex, Gidc, Vapi, Pardi, Valsad,, Valsad, Gujarat, 396195.
U33112GJ2018PTC104775
104775
16 October 2018
₹1.00 M
₹1.00 M
Roc Ahmedabad
Unlisted
Active
Explore comprehensive insights into Albero Pharma Private Limited — covering financial performance, compliance records, Competitor, shareholding patterns, directors, key metrics, and litigation history. Unlock to see detailed insights and stay informed.
Access Report
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
| Chandraben Hiralal Thakkar | Director | 11 May 2021 | Current |
| Vishal Rajendrabhai Chaudhari | Director | 14 Nov 2018 | Current |
| Karunendra Pandey | Director | 16 Oct 2018 | Current |
| Anant Gamanlal Chaudhari | Director | 29 Mar 2023 | Current |
| Umaben Rajankumar Thakar | Director | 19 Aug 2021 | Current |
| Name | Designation | Cessation | Status |
|---|---|---|---|
| Pramod Abcsdd | Additional Director | 30 Sep 2022 | Past |
| Pramod Abcsdd | Additional Director | 21 Dec 2019 | Past |
| Pramod Abcsdd | Director | 25 May 2020 | Past |
| Pramod Abcsdd | Director | 11 May 2021 | Past |
| Pramod Abcsdd | Additional Director | 29 Sep 2023 | Past |
| Pramod Abcsdd | Director | 19 Aug 2021 | Past |
Discover detailed profiles of directors and KMP - Unlock leadership insights today!
Albero Pharma Private Limited, for the financial year ended 2021, experienced modest growth in revenue, with a 2.02% increase. The company also saw a slight decrease in profitability, with a 9.3% decrease in profit. The company's net worth Soared by an impressive increase of 13.55%.
| Metrics |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
| ||||||
| Revenue from Operations |
| ||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
In 2021, Albero Pharma had a promoter holding of 100.00%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Reveal ownership structures and financial performance - Get instant access now!
There are no open charges registered against the company as per our records.
Unlock and access historical data on people associated with Albero Pharma, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.
Gain comprehensive insights into the Deals and Valuation data of Albero Pharma, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Albero Pharma's trajectory.
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
Albero Pharma Private Limited last Annual general meeting of members was held on 30 Sep 2024 as per latest MCA records. was recorded as a recent event.
Progress on Albero Pharma Private Limited has filed its annual Financial statements for the year ended 31 Mar 2024 with Roc Ahmedabad. was documented.
Progress on Anant Gamanlal Chaudhari was appointed as a Director was appointed as a Director on 29 Mar 2023 & has been associated with this company since 2 years 7 months . was documented.
The activity Umaben Rajankumar Thakar was appointed as a Director was appointed as a Director on 19 Aug 2021 & has been associated with this company since 4 years 3 months . was completed.
Chandraben Hiralal Thakkar was appointed as a Director was appointed as a Director on 11 May 2021 & has been associated with this company since 4 years 6 months . was recorded as a recent event.
The activity Vishal Rajendrabhai Chaudhari was appointed as a Director was appointed as a Director on 14 Nov 2018 & has been associated with this company since 7 years 11 days . was completed.
The CIN of Albero Pharma Private Limited is U33112GJ2018PTC104775.
Albero Pharma Private Limited is headquartered at P-491/2 492 1 2 3, Shop No. 105, Amidhara Complex, Gidc, Vapi, Pardi, Valsad,, Valsad, Gujarat, 396195.
Albero Pharma Private Limited was incorporated on 16 October 2018.
The current directors of Albero Pharma Private Limited are
The primary industry of Albero Pharma Private Limited is Manufacturing.
Albero Pharma Private Limited is unlisted.
The authorized capital of Albero Pharma Private Limited is ₹1.00 M, and the paid-up capital is ₹1.00 M.
The compliance status of Albero Pharma Private Limited is Compliant.
Search company & director profiles for free and gain access to critical business data.
Company Details
+91-XXXXXXXXXX